Does it matter who provides psychological interventions for medically unexplained symptoms? a meta-analysis

Psychotherapy and Psychosomatics

Volumn 84, Issue 4, 2015, Pages 217-226

  Gerger, Heike ^a,b   Hlavica, Michaela ^a   Gaab, Jens ^b   Munder, Thomas ^a   Barth, Jürgen ^a,c  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Medically unexplained physical symptoms; Meta analysis; Psychological interventions; Somatization; Symptom severity; Treatment provider

Indexed keywords

ARTICLE; EFFECT SIZE; FOLLOW UP; GENERAL PRACTITIONER; HEALTH CARE COST; HUMAN; MEDICALLY UNEXPLAINED SYMPTOM; MENTAL DISEASE; META ANALYSIS; PHYSICAL DISEASE BY BODY FUNCTION; PRIORITY JOURNAL; PSYCHOTHERAPIST; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; COMPARATIVE STUDY; MENTAL DISORDERS; PROCEDURES; SOMATOFORM DISORDERS;

GENERAL PRACTITIONERS; HUMANS; MENTAL DISORDERS; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SOMATOFORM DISORDERS;

EID: 84930246300     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000380914     Document Type: Article

References (71)

1. Fink P, Hansen MS, Oxhøj M-L: The prevalence of somatoform disorders among internal medical inpatients. J Psychosom Res 2004; 56: 413-418.
2. Gureje O, Simon GE: The natural history of somatization in primary care. Psychol Med 1999; 29: 669-676.
3. Nimnuan C, Hotopf M, Wessely S: Medically unexplained symptoms: An epidemiological study in seven specialities. J Psychosom Res 2001; 51: 361-367.
4. Toft T, Fink P, Oernboel E, Christensen K, Frostholm L, Olesen F: Mental disorders in primary care: prevalence and co-morbidity among disorders. Results from the functional illness in primary care (FIP) study. Psychol Med 2005; 35: 1175-1184.
5. Brown RJ: Introduction to the special issue on medically unexplained symptoms: background and future directions. Clin Psychol Rev 2007; 27: 769-780.
6. olde Hartman TC, Borghuis MS, Lucassen PLBJ, van de Laar FA, Speckens AE, van Weel C: Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosom Res 2009; 66: 363-377.
7. Fava GA, Guidi J, Porcelli P, Rafanelli C, Bellomo A, Grandi S, Grassi L, Mangelli L, Pasquini P, Picardi A, Quartesan R, Rigatelli M, Sonino N: A cluster analysis-derived classification of psychological distress and illness behavior in the medically ill. Psychol Med 2012; 42: 401-407.
8. Klaus K, Rief W, Brähler E, Martin A, Glaesmer H, Mewes R: The distinction between 'medically unexplained' and 'medically explained' in the context of somatoform disorders. Int J Behav Med 2013; 20: 161-171.
9. Dimsdale J, Sharma N, Sharpe M: What do physicians think of somatoform disorders? Psychosomatics 2011; 52: 154-159.
10. Wessely S, White PD: There is only one functional somatic syndrome. Br J Psychiatry 2004; 185: 95-96.
11. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 5. Arlington, American Psychiatric Publishing, 2013.
12. Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995; 63: 1-8.
13. Sirri L, Fava GA: Diagnostic criteria for psychosomatic research and somatic symptom disorders. Int Rev Psychiatry 2013; 25: 19-30.
14. van Dessel N, den Boeft M, van der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, Numans ME, van der Horst HE, van Marwijk H: Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev 2014; 11:CD011142.
15. Barsky AJ, Orav EJ, Bates DW: Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005; 62: 903-910.
16. Konnopka A, Schaefert R, Heinrich S, Kaufmann C, Luppa M, Herzog W, König HH: Economics of medically unexplained symptoms: A systematic review of the literature. Psychother Psychosom 2012; 81: 265-275.
17. Arnold IA, de Waal MWM, Eekhof JAH, van Hemert AM: Somatoform disorder in primary care: course and the need for cognitivebehavioral treatment. Psychosomatics 2006; 47: 498-503.
18. Kleinstäuber M, Witthöft M, Hiller W: Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: A meta-analysis. Clin Psychol Rev 2011; 31: 146-160.
19. Kroenke K: Efficacy of treatment for somatoform disorders: A review of randomized controlled trials. Psychosom Med 2007; 69: 881-888.
20. Looper KJ, Kirmayer LJ: Behavioral medicine approaches to somatoform disorders. J Consult Clin Psychol 2002; 70: 810-827.
21. Nezu AM, Nezu CM, Lombardo ER: Cognitive-behavior therapy for medically unexplained symptoms: A critical review of the treatment literature. Behav Ther 2001; 32: 537-583.
22. Sumathipala A: What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med 2007; 69: 889-900.
23. Koelen JA, Houtveen JH, Abbass A, Luyten P, Eurelings-Bontekoe EH, Van Broeckhuysen-Kloth SA, Bühring ME, Geenen R: Effectiveness of psychotherapy for severe somatoform disorder: meta-analysis. Br J Psychiatry 2014; 204: 12-19.
24. Escobar JI, Burnam MA, Karno M, Forsythe A, Golding JM: Somatization in the community. Arch Gen Psychiatry 1987; 44: 713-718.
25. Jüni P, Altman DG, Egger M: Assessing the quality of controlled clinical trials. BMJ 2001; 323: 42-46.
26. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJG, Sterne JAC: Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008; 336: 601-605.
27. Nüesch E, Trelle S, Reichenbach S, Rutjes AWS, Bürgi E, Scherer M, Altman DG, Jüni P: The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ 2009; 339:b3244.
28. Hedges LV, Olkin I: Statistical Methods for Meta-Analysis. New York, Academic Press, 1985.
29. Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Erlbaum, 1988.
30. Lipsey MW, Wilson DB: Practical Meta-Analysis. Thousand Oaks, Sage, 2001.
31. Cuijpers P, van Straten A, Bohlmeijer E, Hollon SD, Andersson G: The effects of psychotherapy for adult depression are overestimated: A meta-analysis of study quality and effect size. Psychol Med 2010; 40: 211-223.
32. Knapp G, Hartung J: Improved tests for a random effects meta-regression with a single covariate. Stat Med 2003; 22: 2693-2710.
33. Higgins JPT, Thompson SG: Controlling the risk of spurious findings from meta-regression. Stat Med 2004; 23: 1663-1682.
34. Shadish WR, Sweeney RB: Mediators and moderators in meta-analysis: There's a reason we don't let dodo birds tell us which psychotherapies should have prizes. J Consult Clin Psychol 1991; 59: 883-893.
35. Higgins JPT: Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 2008; 37: 1158-1160.
36. Rucker G, Schwarzer G, Carpenter JR, Schumacher M: Undue reliance on I 2 in assessing heterogeneity may mislead. BMC Med Res Methodol 2008; 8: 79.
37. Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Steichen TJ, Sterne JAC: METAN: Stata module for fixed and random effects meta-analysis. Boston College Department of Economics, 2006.
38. Egger M, Smith GD, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
39. Aiarzaguena JM, Grandes G, Gaminde I, Salazar A, Sanchez A, Arino J: A randomized controlled clinical trial of a psychosocial and communication intervention carried out by GPs for patients with medically unexplained symptoms. Psychol Med 2007; 37: 283-294.
40. Allen LA, Woolfolk RL, Escobar JI, Gara MA, Hamer RM: Cognitive-behavioral therapy for somatization disorder: A randomized controlled trial. Arch Intern Med 2006; 166: 1512-1518.
41. Arnold IA, de Waal MW, Eekhof JA, Assendelft WJ, Spinhoven P, van Hemert AM: Medically unexplained physical symptoms in primary care: A controlled study on the effectiveness of cognitive-behavioral treatment by the family physician. Psychosomatics 2009; 50: 515-524.
42. Escobar JI, Gara MA, Diaz-Martinez AM, Interian A, Warman M, Allen LA, Woolfolk RL, Jahn E, Rodgers D: Effectiveness of a timelimited cognitive behavior therapy type intervention among primary care patients with medically unexplained symptoms. Ann Fam Med 2007; 5: 328-335.
43. Kocken PL, Joosten-van Zwanenburg E, de Hoop T: Effects of health education for migrant females with psychosomatic complaints treated by general practitioners. Patient Educ Couns 2008; 70: 25-30.
44. Kolk AMM, Schagen S, Hanewald GJFP: Multiple medically unexplained physical symptoms and health care utilization: outcome of psychological intervention and patient-related predictors of change. J Psychosom Res 2004; 57: 379-389.
45. Larisch A, Schweickhardt A, Wirsching M, Fritzsche K: Psychosocial interventions for somatizing patients by the general practitioner: A randomized controlled trial. J Psychosom Res 2004; 57: 507-514.
46. Morriss R, Dowrick C, Salmon P, Peters S, Dunn G, Rogers A, Lewis B, Charles-Jones H, Hogg J, Clifford R, Rigby C, Gask L: Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. Br J Psychiatry 2007; 191: 536-542.
47. Pols RG, Battersby MW: Coordinated care in the management of patients with unexplained physical symptoms: depression is a key issue. Med J Aust 2008; 188(suppl 12):S133-S137.
48. Posse M: Jungian psychotherapy for somatization. Eur J Psychiatry 2004; 18: 23-29.
49. Rosendal M, Olesen F, Fink P, Toft T, Sokolowski I, Bro F: A randomized controlled trial of brief training in the assessment and treatment of somatization in primary care: effects on patient outcome. Gen Hosp Psychiatry 2007; 29: 364-373.
50. Schilte AF, Portegijs PJ, Blankenstein AH, van der Horst HE, Latour MB, van Eijk JT, Knottnerus JA: Randomised controlled trial of disclosure of emotionally important events in somatisation in primary care. BMJ 2001; 323: 86.
51. Schweickhardt A, Larisch A, Wirsching M, Fritzsche K: Short-term psychotherapeutic interventions for somatizing patients in the general hospital: A randomized controlled study. Psychother Psychosom 2007; 76: 339-346.
52. Smith RC, Gardiner JC, Luo Z, Schooley S, Lamerato L, Rost K: Primary care physicians treat somatization. J Gen Intern Med 2009; 24: 829-832.
53. Smith RC, Lyles JS, Gardiner JC, Sirbu C, Hodges A, Collins C, Dwamena FC, Lein C, William Given C, Given B, Goddeeris J: Primary care clinicians treat patients with medically unexplained symptoms: A randomized controlled trial. J Gen Intern Med 2006; 21: 671-677.
54. Speckens AE, van Hemert AM, Spinhoven P, Hawton KE, Bolk JH, Rooijmans HG: Cognitive behavioural therapy for medically unexplained physical symptoms: A randomised controlled trial. BMJ 1995; 311: 1328-1332.
55. Sumathipala A, Hewege S, Hanwella R, Mann AH: Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: A feasibility study in Sri Lanka. Psychol Med 2000; 30: 747-757.
56. Sumathipala A, Siribaddana S, Abeysingha MR, de Silva P, Dewey M, Prince M, Mann AH: Cognitive-behavioural therapy versus structured care for medically unexplained symptoms: randomised controlled trial. Br J Psychiatry 2008: 51-59.
57. Toft T, Rosendal M, Ornbol E, Olesen F, Frostholm L, Fink P: Training general practitioners in the treatment of functional somatic symptoms: effects on patient health in a cluster-randomised controlled trial. Psychother Psychosom 2010; 79: 227-237.
58. van der Feltz-Cornelis CM, van Oppen P, Ader HJ, van Dyck R: Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice. Psychother Psychosom 2006; 75: 282-289.
59. Khan AA, Khan A, Harezlak J, Tu W, Kroenke K: Somatic symptoms in primary care: etiology and outcome. Psychosomatics 2003; 44: 471-478.
60. Guidi J, Rafanelli C, Roncuzzi R, Sirri L, Fava GA: Assessing psychological factors affecting medical conditions: comparison between different proposals. Gen Hosp Psychiatry 2013; 35: 141-146.
61. Porcelli P, Bellomo A, Quartesan R, Altamura M, Iuso S, Ciannameo I, Piselli M, Elisei S: Psychosocial functioning in consultation-liaison psychiatry patients: influence of psychosomatic syndromes, psychopathology and somatization. Psychother Psychosom 2009; 78: 352-358.
62. Sattel H, Lahmann C, Gundel H, Guthrie E, Kruse J, Noll-Hussong M, Ohmann C, Ronel J, Sack M, Sauer N, Schneider G, Henningsen P: Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial. Br J Psychiatry 2012; 200: 60-67.
63. Deary V, Chalder T, Sharpe M: The cognitive behavioural model of medically unexplained symptoms: A theoretical and empirical review. Clin Psychol Rev 2007; 27: 781-797.
64. Freidl M, Piralic Spitzl S, Prause W, Zimprich F, Lehner-Baumgartner E, Baumgartner C, Aigner M: The stigma of mental illness: Anticipation and attitudes among patients with epileptic, dissociative or somatoform pain disorder. Int Rev Psychiatry 2007; 19: 123-129.
65. Rief W, Broadbent E: Explaining medically unexplained symptoms-models and mechanisms. Clin Psychol Rev 2007; 27: 821-841.
66. Tomba E, Bech P: Clinimetrics and clinical psychometrics: macro-and micro-analysis. Psychother Psychosom 2012; 81: 333-343.
67. Crombez G, Beirens K, Van Damme S, Eccleston C, Fontaine J: The unbearable lightness of somatisation: A systematic review of the concept of somatisation in empirical studies of pain. Pain 2009; 145: 31-35.
68. Sirri L, Fava GA, Sonino N: The unifying concept of illness behavior. Psychother Psychosom 2013; 82: 74-81.
69. Mechanic D: Social psychologic factors affecting the presentation of bodily complaints. N Engl J Med 1972; 286: 1132-1139.
70. Katsamanis M, Lehrer PM, Escobar JI, Gara MA, Kotay A, Liu R: Psychophysiologic treatment for patients with medically unexplained symptoms: A randomized controlled trial. Psychosomatics 2011; 52: 218-229.
71. Schaefert R, Kaufmann C, Wild B, Schellberg D, Boelter R, Faber R, Szecsenyi J, Sauer N, Guthrie E, Herzog W: Specific collaborative group intervention for patients with medically unexplained symptoms in general practice: A cluster randomized controlled trial. Psychother Psychosom 2013; 82: 106-119.